Veristat

Veristat is a France-based, full-service CRO with over 30 years of experience, focusing on accelerating clinical development for novel therapeutics in complex areas like rare diseases, oncology, and neurology. The company operates as a strategic partner, offering end-to-end solutions from trial design and execution to regulatory submission, having supported over 105 regulatory approvals. It is a private, revenue-generating services firm that leverages deep therapeutic expertise and a collaborative model to de-risk and expedite its clients' paths to market.

Integrated clinical research service platform combining strategic consulting, clinical operations, biometrics (data management, biostatistics, programming), regulatory affairs, and medical writing. Expertise in adaptive designs, decentralized trial elements, and efficient regulatory submission processes.

Competes in the fragmented global CRO market against large, full-service players (e.g., IQVIA, ICON, Labcorp) and numerous niche CROs. Differentiates through a deep focus on novel/complex therapies, a strong track record of regulatory approvals, and a collaborative partnership model, particularly appealing to small and mid-size biopharma companies.